Mark McGovern Net Worth & Insider Trades

Mark McGovern - Director, Esperion Therapeutics, Inc

As of May 28, 2021

What is Mark McGovern's Net Worth?

The current estimated net worth of Esperion Therapeutics, Inc's Director, Mark McGovern, is estimated to be about $95.96K . Mark McGovern owns about 5,000 units of Esperion Therapeutics, Inc common stock. In the last 6 years at Esperion Therapeutics, Inc, Mark McGovern has sold an estimated value of $0 worth.

What is Mark McGovern's Past Insider Trading?

Mark McGovern's largest purchase order was 5,000 units , worth over $50K on July 7, 2016. In total, Mark McGovern has made about 8 transactions over 6 years of their time at Esperion Therapeutics, Inc. Mark McGovern usually trades in May, with the busiest year in 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Esperion Therapeutics, Inc's Past Insider Trades?

Esperion Therapeutics, Inc's most recent insider trade came on August 8, 2022 by Sheldon L Koenig who bought 8,606 units worth $49.95K . In the last 9 years, insiders at Esperion Therapeutics, Inc have sold an estimated value of $198.14M and bought an estimated value of $137.47M worth of shares. Insider trading is most common in May, with the busiest year in 2018. The most active traders at the company are Timothy Mayleben, President & CEO,  Ag Biotech Bb,  and Target Biotech V .

Esperion Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1